Skip to main content

Full text of "Multiplex PCR followed by restriction length polymorphism analysis for the subtyping of bovine herpesvirus 5 isolates."

See other formats


Maidana et ah BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Veterinary Research 



RESEARCH ARTICLE Open Access 



Multiplex PCR followed by restriction length 
polymorphism analysis for the subtyping of 
bovine herpesvirus 5 isolates 

Silvina Soledad Maidana 1,2 , Cintia Debora Morano 1 , Daniela Cianfrini 4 , Fabricio Souza Campos 5 , 
Paulo Michel Roehe 5 , Bianca Siedler 6 , Gabriel De Stefano 1 , Axel Mauroy 7 , Etienne Thiry 7 * 
and Sonia Alejandra Romera 1,2,3 



Abstract 

Background: Several types and subtypes of bovine herpesviruses 1 and 5 (BoHV-1 and BoHV-5) have been 
associated to different clinical conditions of cattle, making type/subtype differentiation essential to understand the 
pathogenesis and epidemiology of BoHV infections. BoHV-5 subtyping is currently carried out by BstEW restriction 
enzyme analysis (REA) of the complete virus genome. This method allowed the description of three subtypes, one 
of which is the most widespread while the remaining two have so far only been found in South America. The 
present work describes a multiplex PCR followed by REA for BoHV-5 subtyping. 

Results: The method consists in the simultaneous amplification of glycoprotein B and UL54 gene fragments of 534 and 
669 base pairs (bp), respectively, BstEW digestion of amplicons, separation of products in 1% agarose gels, and analysis of 
fragment length polymorphims. The multiplex PCR detected up to 227 BoHV-5 genome copies and 9.2 x 10 5 BoHV-5 
genome copies when DNA was extracted from purified virus or infected tissue homogenates, respectively. The 
applicability of multiplex PCR-REA was demonstrated on 3 BoHV-5 reference strains. In addition, subtyping of two new 
isolates and seventeen previously reported ones (17 BHV-5a and 2 BHV-5b) by this method gave coincident results with 
those obtained with the classic BstEW REA assay. 

Conclusions: Multiplex PCR-REA provides a new tool for the fast and simple diagnosis and subtyping of BoHV-5. 



Background 

Bovine herpesvirus 5 (BoHV- 5) is an alphaherpesvirus re- 
sponsible for meningoencephalitis in young cattle, and is 
antigenically and genetically closely related to bovine her- 
pesvirus 1 (BoHV-1) [1]. The origin and geographic distri- 
bution of BoHV-5 infections are largely unknown, mainly 
due to serological cross-reactivity with BoHV-1 [2]. Spor- 
adic cases of meningoencephalitis by BoHV-5 have been 
reported in Australia [3], USA [4], Italy [5] and Hungary 
[6]. In contrast, BoHV-5 infection and disease appear to be 
more frequent in Argentina and Brazil, where numerous 
outbreaks were described in the last decades [7-11]. The 
rare occurrence of BoHV-5 neurological disease in areas 



* Correspondence: etienne.thiry@ulg.acbe 

'Veterinary Virology and Animal Viral Diseases, Department of Infectious and 
Parasitic Diseases Faculty of Veterinary Medicine, University of Liege, Liege, 
Belgium 

Full list of author information is available at the end of the article 



where BoHV-1 infection is endemic may be explained by 
cross-protection induced by natural infection or vaccin- 
ation [12-14]. 

BoHV-5 infection induces either a subclinical infection 
or disease of moderate severity in adult cattle [15] and le- 
thal encephalitis in young animals [6,7,16]. 

Virological assays are very accurate tools to specifically 
diagnose BoHV-5 infections. Virus isolation in cell culture 
can be performed from fresh or frozen nasal secretions, 
semen or post mortem samples [1]. However, in light of 
recent reports of bovine herpesviruses isolated from dif- 
ferent samples, and responsible for both symptomatic and 
asymptomatic infections [11,17,18], classical diagnostic 
methods are not sufficient for a fast and easy identification 
and subtyping of the infectious virus. 

Several assays are available to differentiate BoHV-5 from 
BoHV-1, including immunoassays using monoclonal anti- 
bodies [19-21], PCR followed by REA [22], nested PCR 



O© 201 3 Maidana et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative 
BlOlVICCl Central Commons Attribution License (httpy/creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited. 



Maidana et ah BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Page 2 of 7 



[13], multiplex PCR [23-25], random amplified poly- 
morphic DNA (RAPD) [26], and multiple PCR sequencing 
assays [27]. Moreover, BstEll restriction enzyme analysis 
(REA) of the complete virus genome can differentiate be- 
tween BoHV-5 subtypes; but the technique is laborious 
and needs substantial amounts and quality of viral DNA 
[28,29]. In addition, a recently described UL27PCR-REA 
[11] assay has been shown to differentiate between BoHV- 
5 subtypes a and b but it cannot differentiate the subtype c. 

We here describe a molecular technique that allows the 
detection and differentiation of all BoHV-5 subtypes. We 
also report the identification and characterization of two 
new BoHV-5 isolates from the Argentinean Provinces of 
Buenos Aires and Chaco. One of them corresponds to a 
symptomatic case obtained during an outbreak of neuro- 
logical disease in a cattle herd, while the other corresponds 
to a non symptomatic case isolated from a bovine semen 
sample. 

This development could be epidemiologically relevant in 
areas where BoHV-5 infection is endemic, and provides a 
new tool for the fast diagnosis and subtyping of BoHV-5. 

Results 

Differential PCR for BoHVI and BoHV5 

The new virus isolates 674 and 2010 were tested by 
multiplex PCR [24] and shown to be BoHV-5. 

REA 

One of the new field isolates (2010) showed a BstEll REA 
pattern similar to reference strain N569, which is the BoHV- 
5a prototype, and the other (674) showed a pattern similar 
to reference strain A663, the BoHV-5b prototype (Figure 1). 
A double 3 kb band was observed in the first case, but it fell 
outside of the area used for subtype classification. 

Determination of a differential restriction site for a and c 
subtypes 

Fragments (500 bp) of the UL54 gene from BoHV-5 sub- 
types a (N569), b (A663 reference strain) and c (IS097/89) 
were sequenced. Sequence alignment revealed a point muta- 
tion (G to A) in the BstEll restriction site for subtype c 
(1879 nt position, NC_005261.2), as compared to subtype a, 
responsible for the variation in the REA pattern (Figure 2). 
This point mutation did not result in an amino acid change. 

Multiplex UL27/UL54 PCR and BstEll restriction analysis 

In the new assay developed in this work, the differential 
expected band pattern for each of the three BoHV-5 sub- 
types after multiplex PCR-REA is shown in Figure 3. The 
PCR products after digestion showed different cleaved com- 
binations. The band of 669 bp is cleaved into two bands of 
408 and 248 bp. Moreover the band of 534 bp is cleaved 
into two bands of 382 and 152 bp. Isolates 674 and 2010 
showed band patterns similar to BoHV-5b and BoHV-5a 




1 2 3 4 5 6 7 



Figure 1 Subtyping of new BoHV-5 isolates from Argentina. 

Bstfl restriction endonuclease profiles of isolates 674 and 2010 
(lanes 5 and 6) and N569, A663 and IS097/89 reference strains (lanes 
2, 3 and 4), M: DNA size marker (lambda Hind III, Invitrogen). 



prototypes, respectively (Figure 4). In addition, when DNA 
of the three different BoHV-1 subtypes was used as tem- 
plate, amplification products could not be digested by BstEll 
(data not shown). 

Sensitivity of the test 

The multiplex PCR assay detected as few as 305 to 455 
ng/ul of purified BoHV-5 DNA or approximately 203 to 
303 genome copies. In the case of DNA extracted from 
infected tissue homogenates the assay detected down to 
9.200 genome copies. 

Discussion 

In countries like Argentina and Brazil where circulation of 
BoHV-5 is high and viral subtypes not described elsewhere 
in the world occur, there is a need for rapid and easy diag- 
nostic tools which allow the classification of viral species 
and subtypes. In this work, a new multiplex PCR-REA that 
easily identifies all BoHV-5 subtypes was developed and im- 
proves previous assay reported by Claus [24]. The latter can 
be used as a confirmatory test for the detection of this virus 
and only allows species differentiation between BoHV-1 and 
BoHV-5, while our multiplex PCR - REA permits simultan- 
eous subtyping of the isolates. This method was applied to 
17 previously characterized virus isolates [11] and 2 newly 



Maidana et ah BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Page 3 of 7 



1810 1820 1830 

.... | .... | .... | .... | .... | .... | 
NC_005261.2 CTTGTGCGTGTCCAAGGCGTCGATGAAGCC 

BoHV5b 

BoHV5c C 



1840 1850 1860 

.... | .... | .... | .... | .... | .... | 
NX_005261.2 CGCCACGCAAGCCCCAGGGATGTACTCCTC 

BoHVSb 

BoHVSc 



1890 
I 



1870 1880 
.... | .... | .... | . . 
NC_005261.2 CAACGGCGCGTCGCCCACfCGI t AC t 1 C ( G A 

BoHVSb 

BoHVSc 



1910 



1920 



1900 

.... | .... | .... | .... | .... | .... | 
NC 005261.2 C AGCGGC ACGCGCTCTGCGCCGGAGCGC AC 

BoHVSb 

BoHV5c 



1930 



1940 



1950 



NC 005261.2 CGCGCGGCTGAGGCGCGCCAGCATCACGAA 

BoHVSb 

BoHVSc 

I960 1970 1980 

.... | .... | .... | .... | .... | .... | 
NC_005261.2 CATGTACGAGGCTGGGCAGGTGGCGAGGCT 

BoHV5b 

BoHV5c 



1990 2000 2010 

.... | .... | .... | .... | .... | .... | 
NC_005261.2 TAGCCGCCGCGCGGCGCAGAGCTCCTCGAG 

BoHVSb 

BoHV5c 

Figure 2 Multiple nucleotide alignment of UL54 sequences from BoHV-5a (Genbank accession numbers NC_005261 .2), BoHV-5b (A663) 
and BoHV-5c (IS097/89). Dots indicate conserved nucleotides, flstfll restriction site has been boxed. 



UNDIGESTED DIGESTED 
PCR PRODUCTS PCR PRODUCTS 




Figure 3 Scheme expected restrictions patterns with BsfEII of multiplex PCR product of BoHV-5 subtypes M: molecular weight marker. 

The products of the undigested multiplex PCR showed two bands of 669 and 534 bp. The two bands, only the 669 bp one and only the 534 bp 
one are digested in subtypes a, b and c respectively. 



Maidana et ah BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Page 4 of 7 



Subt. 



Subt. 
b 



Subt. 



REPRESENTATIVE FIELD ISOLATES 



UD D UD D UD D UD D MWUD D UD D UD D UD D UD D 



UD D UD D MW 



Neg. N569 A663 IS097/89 674 2010 

Ctrol 

Figure 4 Multiplex PCR-REA applied PCR amplicons before and after digestion with BsfEII restrictions enzyme of the Argentine BoHV-5 
representative isolates and reference strains. The lanes corresponding to the most recent isolates are marked. Ud: undigested; D: digested; 
Subt: subtype; Neg.: Control Negative; Ref: reference strain. M: 1 Kb plus DNA size marker. 



identified ones. Results were identical to those obtained with 
the classical BoHV-5 subtyping technique (BstEU restriction 
profile of the entire genome). When different BoHV-1 sub- 
types were used as template for this multiplex PCR-REA, 
fragments of different molecular weight, as compared to 
BoHV-5, were obtained. Multiplex PCR-REA is more sensi- 
tive, faster, less laborious and more economical than the 
traditional whole genome restriction analysis, and can detect 
DNA both from purified virus and tissues. 

The protocol uses two pairs of primers for the simultan- 
eous amplification of UL27 and UL54 segments. Due to the 
molecular weight differences in the amplified fragments 
after digestion, it is possible to clearly distinguish the char- 
acteristic bands of each subtype by visual analysis of agarose 
gels. Amplicon sequencing allowed to find the point muta- 
tion responsible for the change on the restriction site of the 
enzyme BstEll and thus, for the different profiles obtained 
for a and c subtypes (G-1879 nt-A genbank accession num- 
ber: NC_005261.2). This mutation was, until now, only ob- 
served in subtype c (IS097/89) strain, isolated in Brazil 
[29]. We showed here the analysis of one out of two 
BoHV-5c subtypes reported until now in the world. 

The method showed a detection sensitivity of 227 BoHV-5 
genome copies of purified virus and 9.2 x 10 s BoHV-5 gen- 
ome copies from tissue samples. 

Nineteen BoHV-5 field isolates, including two newly 
identified ones, were subtyped using the described method. 
One of the two new isolates included in this work was iso- 
lated from cryopreserved bovine semen. To our knowledge, 
this is the first report of BoHV-5 virus identification from 
semen in Argentina. This sample was classified as subtype 
b by multiplex PCR-REA, constituting the last and one of 
the three BoHV-5b isolates characterized so far. Although 
no virulence differences between a and b subtypes have 
been found [30], subtype identification is relevant to under- 
stand virus genetic variability and contribute to molecular 
epidemiology studies. Noteworthy, the virally contaminated 
semen was harvested from an apparently healthy bull. This 



finding agrees with similar results obtained in Brazil and 
Australia [17,18]. Whether BoHV-5 transmitted to a cow 
via artificial insemination (AI) can cause neurological disor- 
ders in the recipient remains to be determined. Given the 
widespread use of AI to diversify cattle stocks, detection of 
animal viruses in semen, either by virus isolation or PCR, is 
crucial. In conclusion, the multiplex PCR-REA described in 
this work provides a new tool for the fast diagnosis and 
subtyping of BoHV-5. This development can aid in the un- 
derstanding and control of these detrimental bovine viral 
infections. 

Conclusion 

Fast and easy tools for the characterization of BoHV-5 viral 
isolates are required. Since, due to technical limitations, se- 
quencing is not an option, the multiplex PCR - REA sys- 
tem described in this work provides an attractive tool for 
the improved control of BoHV-5 viral infections. 

Methods 

Cell culture and virus isolates 

During a routine health test, a BoHV-5-positive semen 
sample was obtained in 2010 from a clinically healthy bo- 
vine from the Argentinean Province of Chaco (isolate 674). 
The semen sample was diluted 1:6 in fetal calf serum (FCS) 
and inoculated onto bovine testis cells in minimal essential 
medium (MEM) containing 10% FCS. Cells were incubated 
at 37°C in a 5% CO2 atmosphere, and daily checked for cy- 
topathic effects (CPE). The second characterized isolate 
was obtained from an animal of about 4 months of age at 
weaning stage from the Argentine Province of Buenos 
Aires isolated in 2010 (isolate 2010). A typical outbreak 
with nervous symptoms and 20% lethality occurred in the 
50-catle herd to which this calf belonged. One gram of 
brain tissue of this animal was homogenized, suspended in 
MEM containing 10% FCS and clarified at 11 000 x g for 
20 min at 4°C. Then, half of the supernatant was inocu- 
lated into bovine testis cells in MEM containing 10% FCS 



Maidana et ah BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Page 5 of 7 



and the other half was used for DNA extraction. Isolates 
674 and 2010 originated therefore from samples sent to 
diagnostic laboratories for routine testing and are not 
subjected to a prior approval by the animal welfare com- 
mittee. Three BoHV-5 reference strains were used as sub- 
type controls: N569 (BoHV-5a), A663 (BoHV-5b) and ISO 
97/87 (BoHV-5c). After standardization of the multiplex 
PCR assay, the method was tested on the two new isolates 
mentioned above and 17 previously characterized BoHV-5 
(16 BoHV-5a and 1 BoHV-5b) field isolates [11]. 

DNA extraction for PCR 

The infected cell culture supernatant from semen and the 
supernatant of homogenized tissue of the BoHV-5 positive 
sample were subjected to DNA extraction using QIAamp 
DNA Mini kit (Qiagen, Hilden, Germany) according to 
the manufacturer's protocol. Purified DNA was stored at - 
20°C until testing. DNA concentration was deduced from 
absorbance measured in a spectrophotometer. 

Differential PCR for BoHV-1 and BoHV-5 

To identify the viral species of isolates 674 and 2010, the 
multiplex PCR designed by Claus and collaborators [24] 
was carried out. Amplification products were of 354 bp and 
159 bp for BoHV-1 and BoHV-5, respectively. Products 
were analyzed on 1% agarose gel electrophoresis, stained 
with ethidium bromide (0.5 (ig/ml) in TBE buffer (89 mM 
Tris, 89 mM boric acid, 2 mM EDTA, pH8.4), and visual- 
ized under UV light. 

Classic subtyping of BoHV-5 by restriction endonuclease 
analysis (REA) 

Field isolates 674 and 2010 were inoculated in tissue culture 
flaks (175 cm ) with nearly confluent, overnight grown 
MDBK (Madin Darby bovine kidney) monolayers, at a 
multiplicity of infection of 0.1, and incubated at 37°C and 
5% CO2. Post infection cultures were frozen at -80°C. After 
two successive rounds of freezing and thawing, clarification 
was carried out at 3000 rpm for 20 min at 4°C. Purification 
and extraction of viral DNA was performed as detailed by 
Maidana et al. [11]. 

Four ug of viral DNA from each reference strain and field 
isolate (2010 and 674) were incubated overnight with BstEH 
restriction enzyme (1U) under the conditions recommended 
by the manufacturer (Promega, Wisconsin, USA). Digestion 
products were separated overnight by electrophoresis on 
0.7% agarose gels at 50 V using TBE buffer. Gels were 
stained with ethidium bromide and photographed under 
UV light. 

Identification of differential restriction sites between 
subtype a and c 

Although differential PCRs to discriminate between BoHV- 
1 and BoHV-5, or between BoHV5a and b subtypes have 



been developed [11,24], subtype c is still indistinguishable 
by these techniques. In silico analysis showed that a site in- 
cluded in the open reading frame of the UL54 gene serves 
to differentiate subtype c from the other two. Primers were 
designed based on the published sequence of BoHV-5 
(Genbank accession number: NC_005261.2) (UL54F: TAT- 
AAC-CCC-CTC-AAC-AAA-AT (nt 1631 to 1650) and 
UL54R: TCT-GCG-AGT-ACC-AGG-TGC-CG nt 2280 to 
2300). DNA sequence analysis to locate polymorphic regions 
within the UL54 target gene was performed using Vector 
NTI Suite version 8.0 (Invitrogen, Merelbeke, Belgium). 

The assay was performed with purified DNA from strains 
of different subtypes 

Amplification was carried out in a 50 ul reaction mix 
containing 5 ng of template DNA, Taq DNA polymerase 
buffer (NEB, Ipswich, MA, USA), 2 mM MgCl 2 , 6% 
DMSO, 200 uM dNTPs, 0.3 uM of both forward and re- 
verse primers and 1U Taq DNA polymerase (NEB). 
Annealing temperatures were optimized for each primer 
pair. The PCR program consisted of 10 min at 96°C, 
followed by 35 cycles of 1 min at 96°C; 1 min at 58°C and 
1 min at 72°C with a final extension step of 10 min at 
72°CThe resulting products were separated by electro- 
phoresis in 1% agarose gels and visualized under UV light 
after ethidium bromide staining. Amplified products were 
purified using Illustra GFX'" PCR, DNA and gel band puri- 
fication kit (GE Healthcare, Diegem, Belgium). The quality 
of all DNA preparations was evaluated by agarose gel elec- 
trophoresis. Sequencing reactions were performed with 
BigDye Terminator v3.0 kit (Applied Biosystems, Lennik, 
Belgium) and analyzed in an ABI Prism 3730 DNA 
Analyzer (Applied Biosystems). 

Each PCR product of reference strains was sequenced 
twice in both directions using forward and reverse primers. 
Nucleotide and predicted amino acid sequences were 
edited; aligned and analyzed with BioEdit version 7.0.5.3 
[31] to determine single nucleotide polymorphisms at 
BstEH restriction sites. 

Multiplex PCR-REA assay for BoHV-5 subtyping 

UL27 PCR assay [11] was modified for easy discrimination 
between three BoHV-5 subtypes. The above described 
UL54 primers that amplify a fragment of 669 bp were in- 
corporated into the UL27 PCR [11]. As template, total gen- 
omic material of the three subtypes of BoHV-5 was used. 
The expected results of this multiplex PCR are two bands 
of 669 bp and 534 bp, respectively. The reaction mix with 
two pair primers (UL54F-UL54R, UL27F-UL27R) and the 
PCR program used were the same as described above. 

Aliquots (25 ul) of the PCR products were incubated with 
BstEH, while the remaining 25 ul were used as undigested 
control. The resulting products were separated by electro- 
phoresis in 1% agarose gels and visualized under UV light 



Maidana et ah BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Page 6 of 7 



after ethidium bromide staining. The pattern of expected 
products before and after digestion is shown in Figure 3. 

The applicability of multiplex PCR-REA was demon- 
strated on reference strains corresponding to the 3 different 
subtypes of each BoHV-5 as well as on 17 previously char- 
acterized BoHV-5 fields isolates [11]. 

Sensitivity of the test 

To evaluate the sensitivity of the multiplex PCR, 10-fold 
serial dilutions of DNA obtained from different types of 
samples (purified virus and infected tissue homogenates) 
were used as template. Then copy numbers were calcu- 
lated based on mass estimations of the entire genome of 
BoHV-5 mass and of the DNA samples analyzed. 

Competing interests 

The authors declare that there are no competing interests. 
Authors' contributions 

SM and SR designed the experiments, analyzed the data and drafted the 
manuscript together. SM performed the experiments. FC, PR and BS kindly 
provided the reference strains. ET and AM participated in the interpretation 
of data and preparation of the manuscript draft. CM, DC and GD helped 
with virus amplification on cell cultures. All authors read and approved the 
final manuscript. 

Acknowledgments 

The authors wish to thank Monica Florin-Christensen (1NTA) and Maria Isabel 
Craig (INTA) for revising the manuscript and Matias Ottaviani for help in the 
figures design. This work was supported by Fonds de la Recherche Scientifique 
(FRS-FNRS, Belgium) and CONICET (Argentina). SM is a CONICET fellow. 
'Etienne Thiry and Sonia Alejandra Romera are co-last authors. 

Author details 

'instituto de Virologia, Centra de Investigaciones en Ciencias Veterinarias y, 
Agronomicas (CICVyA), Instituto de tecnologia Agropecuaria (INTA), N. 
Repetto, y Los Reseros S/N, CC25, (B1712WAA), Castelar, Buenos Aires, 
Argentina. 2 Consejo Nacional de Investigaciones, Cientificas y Tecnologicas 
(CONICET), Rivadavia 1917, (C1033AAJ), Ciudad Autonoma de Buenos Aires, 
Argentina. 3 lnmunologfa, Universidad del Salvador, Champagnat 1599-Ruta 
Panamericana-Km 54.5 Pilar, -B1630AHU-Provincia de Buenos Aires, 
Argentina. 4 Tecnovax SA, Luis Viaie 2835, 1416, Ciudad Autonoma de Buenos 
Aires, Argentina. 5 Virology Laboratory, Department of Microbiology, 
Immunology and Parasitology, Institute of Basic Health Sciences, Federal 
University of Rio Grande do Sul (UFRGS), Av. Sarmento Leite 500, Porto 
Alegre 90050-170, Rio Grande do Sul (RS), Brazil. 6 Laborat6rio de 
Bioprocessos, Universidade Federal de Pelotas, Rua Gomes Carneiro, 1, 
96010-610, Pelotas, Brasil. 'Veterinary Virology and Animal Viral Diseases, 
Department of Infectious and Parasitic Diseases Faculty of Veterinary 
Medicine, University of Liege, Liege, Belgium. 

Received: 21 January 2013 Accepted: 1 June 2013 
Published: 4 June 2013 

Reference 

1 . Del Medico Zajac MP, Ladelfa MF, Kotsias F, Muylkens B, Thiry J, Thiry E, 
Romera SA: Biology of bovine herpesvirus 5. Vet J 2010, 184:138-145. 

2. Vogel FS, Caron L, Flores EF, Weiblen R, Winkelmann ER, Mayer SV, Bastos 
RG: Distribution of bovine herpesvirus type 5 DNA in the central nervous 
systems of latently, experimentally infected calves. J Clin Microbiol 2003, 
41:4512-4520. 

3. French EL: A specific virus encephalitis in calves: isolation and 
characterization of the causal agent. Aust Vet J 1 962, 38:21 6-221 . 

4. D'Offay JM, Mock RE, Fulton RW: Isolation and characterization of 
encephalitic bovine herpesvirus type 1 isolates from cattle in North 
America. Am J Vet Res 1993, 54:534-539. 



5. Moretti B, Orfei Z, Mondino G, Persechino A: [Isolation of the Infectious 
Bovine Rhinotracheitis (Ibr) Virus in Italy. (Preliminary Note). Nuovi Ann Ig 
Microb 1964, 15:18-22. 

6. Bartha A, Hajdu G, Aldasy P, Paczolay G: Occurrence of encephalitis caused 
by infectious bovine rhinotracheitis virus in calves in hungary. Acta Vet 
Acad SciHung 1969, 19:145-151. 

7. Carrillo BJ, Ambrogi A, Schudel AA, Vazquez M, Dahme E, Pospischil A: 
Meningoencephalitis caused by IBR virus in calves in Argentina. Zbl Vet 
Med B J Vet Med 1 983, 30:327-332. 

8. Weiblen R, De Barros CS, Canabarro TF, Flores IE: Bovine 
meningoencephalitis from IBR virus. Vet Rec 1989, 124:666-667. 

9. Roehe PM, Silva TC, Nardi NB, Oliveira LG, Rosa JCA: Differentiation 
between viruses of infectious bovine rhinotracheitis (BHV-1) and bovine 
encephalitis herpesvirus (BHV-5) with monoclonal antibodies. Pesq Vet 
Bras 1997, 17:41-44. 

10. Rissi DR, Pierezan F, Silva MS, Flores EF, De Barros CS: Neurological disease 
in cattle in southern Brazil associated with Bovine herpesvirus infection. 
J Vet Diagn Invest 2008, 20:346-349. 

1 1 . Maidana SS, Ladelfa MF, Perez SE, Lomonaco PM, Del Medico Zajac MP, 
Odeon A, Blanco Vera J, Combessies G, Fondevila N, Palacios M, et ah 
Characterization of BoHV-5 field strains circulation and report of 
transient specific subtype of bovine herpesvirus 5 in Argentina. BMC Vet 
Res 2011, 7:8. 

12. Thiry E, Muylkens B, Meurens F, Gogev S, Thiry J, Vanderplasschen A, 
Schynts F: Recombination in the alphaherpesvirus bovine herpesvirus 1. 
Vet Microbiol 2006, 1 1 3:1 71 -1 77. 

13. Cascio KE, Belknap EB, Schultheiss PC, Ames AD, Collins JK: Encephalitis 
induced by bovine herpesvirus 5 and protection by prior vaccination or 
infection with bovine herpesvirus I.J Vet Diagn Invest 1999, 11:134-139. 

14. Del Medico Zajac MP, Puntel M, Zamorano PI, Sadir AM, Romera SA: BHV-1 
vaccine induces cross-protection against BHV-5 disease in cattle. Res Vet 
Sci 2006, 81:327-334. 

15. Ashbaugh SE, Thompson KE, Belknap EB, Schultheiss PC, Chowdhury S, 
Collins JK: Specific detection of shedding and latency of bovine 
herpesvirus 1 and 5 using a nested polymerase chain reaction. J Vet 
Diagn Invest 1 997, 9:387-394. 

1 6. Meyer G, Lemaire M, Ros C, Belak K, Gabriel A, Cassart D, Coignoul F, Belak S, 
Thiry E: Comparative pathogenesis of acute and latent infections of calves 
with bovine herpesvirus types 1 and 5. Arch Virol 2001, 146:633-652. 

17. Diallo IS, Corney BG, Rodwell BJ: Detection and differentiation of bovine 
herpesvirus 1 and 5 using a multiplex real-time polymerase chain 
reaction. J Virol Methods 201 1, 175:46-52. 

18. Oliveira MT, Campos FS, Dias MM, Velho FA, Freneau GE, Brito WM, Rijsewijk 
FA, Franco AC, Roehe PM: Detection of bovine herpesvirus 1 and 5 in 
semen from Brazilian bulls. Theriogenology 201 1, 75:1 139-1 145. 

19. Metzler AE, Matile H, Gassmann U, Engels M, Wyler R: European isolates of 
bovine herpesvirus 1: a comparison of restriction endonuclease sites, 
polypeptides, and reactivity with monoclonal antibodies. Arch Virol 
1985, 85:57-69. 

20. Keuser V, Schynts F, Detry B, Collard A, Robert B, Vanderplasschen A, 
Pastoret PP, Thiry E: Improved antigenic methods for differential 
diagnosis of bovine, caprine, and cervine alphaherpesviruses related to 
bovine herpesvirus 1 . J Clin Microbiol 2004, 42:1 228-1 235. 

21 . Thiry J, Tempesta M, Camera M, Tarsitano E, Muylkens B, Meurens F, Thiry E, 
Buonavoglia C: Clinical protection against caprine herpesvirus 1 genital 
infection by intranasal administration of a live attenuated glycoprotein E 
negative bovine herpesvirus 1 vaccine. BMC Vet Res 2007, 3:33. 

22. Ros C, Belak S: Studies of genetic relationships between bovine, caprine, 
cervine, and rangiferine alphaherpesviruses and improved molecular 
methods for virus detection and identification. J Clin Microbiol 

1999, 37:1247-1253. 

23. Alegre M, Nanni M, Fondevila N: Development of a multiplex polymerase 
chain reaction for the differentiation of bovine herpesvirus-1 and -5. 

J Vet Med 2001, 48:613-621. 

24. Claus MP, Alfieri AF, Folgueras-Flatschart AV, Wosiacki SR, Medici KC, Alfieri 
AA: Rapid detection and differentiation of bovine herpesvirus 1 and 5 
glycoprotein C gene in clinical specimens by multiplex-PCR. J Virol 
Methods 2005, 128:183-188. 

25. Thiry J, Widen F, Gregoire F, Linden A, Belak S, Thiry E: Isolation and 
characterisation of a ruminant alphaherpesvirus closely related to 
bovine herpesvirus 1 in a free-ranging red deer. BMC Vet Res 2007, 3:26. 



Maidana et al. BMC Veterinary Research 2013, 9:1 1 1 
http://www.biomedcentral.eom/1746-6148/9/1 1 1 



Page 7 of 7 



26. Afonso DA, Ortega LS, Redondo RA, Trindade Gde S, Barbosa-Stancioli EF: 
Characterization of field bovine herpesvirus samples using random 
amplified polymorphic DNA (RAPD). J Virol Methods 2007, 140:200-205. 

27. Del Medico Zajac MP, Romera SA, Ladelfa MF, Kotsias F, Thiry J, Ziant D, 
Meurens F, Keil GM, Thiry E, Muylkens B: Characterization of interspecific 
recombinants generated from closely related bovine herpesviruses 1 and 5 
through multiple PCR sequencing assays. J Virol Methods 2009, 161:75-83. 

28. Brake F, Studdert MJ: Molecular epidemiology and pathogenesis of 
ruminant herpesviruses including bovine, buffalo and caprine 
herpesviruses I and bovine encephalitis herpesvirus. Aust Vet J 1985, 
62:331-334. 

29. D'Arce RC, Almeida RS, Silva TC, Franco AC, Spilki F, Roehe PM, Arns CW: 
Restriction endonuclease and monoclonal antibody analysis of Brazilian 
isolates of bovine herpesviruses types 1 and 5. Vet Microbiol 2002, 
88:315-324. 

30. Ladelfa MF, Del Medico Zajac MP, Kotsias F, Delgado F, Muylkens B, Thiry J, 
Thiry E, Romera SA: Comparative study on the in vitro and in vivo 
properties of two bovine herpesvirus-5 reference strains. Acta Vet Scand 
2011, 53:37. 

31. Hall TA: BioEdit: a user-friendly biological sequence alignment editor and 
analysis program for Windows 95/98/NT. Nud Acids Symp Ser 1999, 41:95-98. 

' > 

doi:l 0.1 1 86/1 746-61 48-9-1 1 1 

Cite this article as: Maidana et al:. Multiplex PCR followed by restriction 
length polymorphism analysis for the subtyping of bovine herpesvirus 5 
isolates. BMC Veterinary Research 2013 9:1 1 1. 



Submit your next manuscript to BioMed Central 
and take full advantage of: 

• Convenient online submission 

• Thorough peer review 

• No space constraints or color figure charges 

• Immediate publication on acceptance 

• Inclusion in PubMed, CAS, Scopus and Google Scholar 

• Research which is freely available for redistribution 



Submit your manuscript at /^'\ n! _, ul _-| r Q r,tr=l 

www.biomedcentral.com/submit ammBa central 



V